Aristopharma Ltd. has launched Naburel to provide effective pain and inflammation relief for arthritis patients.
Naburel is a non-steroidal anti-inflammatory drug (NSAID) indicated for the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. It helps reduce joint pain, swelling and stiffness. Nabumetone (Naburel) is a prodrug that is converted into its active form after liver metabolism, offering reduced renal and gastrointestinal side effects compared to conventional NSAIDs. It acts by inhibiting cyclooxygenase (COX) enzymes and provides effective relief from pain and inflammation in patients with chronic arthritis.
FR
DE